aTyr Pharma, Inc.
ATYR
Price:
$0.8278
Market Cap:
$81.11M
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase fo...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
ATYR
PE Ratio
[-1.00]
ROE
[-100.11%]
Current Ratio
[5.93]
Dividend Yield
[0%]
Enterprise Value
[87.32M]
Dividend History
The ROE as of December 2025 (TTM) for aTyr Pharma, Inc. (ATYR) is -100.11%
According to aTyr Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -100.11%. This represents a change of 302.94% compared to the average of -24.85% of the last 4 quarters.
aTyr Pharma, Inc. (ATYR) Historical ROE (quarterly & annually)
How has ATYR ROE performed in the past?
The mean historical ROE of aTyr Pharma, Inc. over the last ten years is -71.55%. The current -100.11% ROE has changed 39.93% with respect to the historical average. Over the past ten years (40 quarters), ATYR's ROE was at its highest in in the March 2020 quarter at 4.16%. The ROE was at its lowest in in the September 2025 quarter at -32.09%.
Average
-71.55%
Median
-69.24%
Minimum
-111.41%
Maximum
-30.89%
aTyr Pharma, Inc. (ATYR) ROE by Quarter and Year
Discovering the peaks and valleys of aTyr Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.93%
Maximum Annual ROE = -30.89%
Minimum Annual Increase = -255.85%
Minimum Annual ROE = -111.41%
| Year | ROE | Change |
|---|---|---|
| 2024 | -91.44% | 64.51% |
| 2023 | -55.58% | -12.39% |
| 2022 | -63.44% | 105.35% |
| 2021 | -30.89% | -39.73% |
| 2020 | -51.26% | -53.99% |
| 2019 | -111.41% | 8.62% |
| 2018 | -102.57% | 36.69% |
| 2017 | -75.04% | -18.55% |
| 2016 | -92.12% | 120.93% |
| 2015 | -41.70% | -255.85% |
aTyr Pharma, Inc. (ATYR) Average ROE
How has ATYR ROE performed in the past?
The current ROE of aTyr Pharma, Inc. (ATYR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-70.15%
5-year avg
-58.52%
10-year avg
-71.55%
aTyr Pharma, Inc. (ATYR) ROE vs. Peers
How is ATYR’s ROE compared to its peers?
aTyr Pharma, Inc.’s ROE is greater than ALX Oncology Holdings Inc. (-115.67%), greater than CAMP4 Therapeutics Corporation (-131.20%), greater than Quince Therapeutics, Inc. (-186.08%), greater than Metagenomi, Inc. Common Stock (-38.76%), greater than Repare Therapeutics Inc. (-57.56%), greater than Unicycive Therapeutics, Inc. (-184.07%), greater than Relmada Therapeutics, Inc. (-223.17%), greater than Acrivon Therapeutics, Inc. Common Stock (-53.71%), greater than MindWalk Holdings Corp. (-114.30%), greater than Precision BioSciences, Inc. (-213.79%),
| Company | ROE | Market cap |
|---|---|---|
| -115.67% | $74.28M | |
| -131.20% | $72.00M | |
| -186.08% | $200.45M | |
| -38.76% | $67.21M | |
| -57.56% | $95.84M | |
| -184.07% | $114.80M | |
| -223.17% | $293.33M | |
| -53.71% | $76.05M | |
| -114.30% | $95.54M | |
| -213.79% | $66.54M |
Build a custom stock screener for aTyr Pharma, Inc. (ATYR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like aTyr Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
aTyr Pharma, Inc. (ATYR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like aTyr Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is aTyr Pharma, Inc.'s ROE?
How is the ROE calculated for aTyr Pharma, Inc. (ATYR)?
What is the highest ROE for aTyr Pharma, Inc. (ATYR)?
What is the 3-year average ROE for aTyr Pharma, Inc. (ATYR)?
What is the 5-year average ROE for aTyr Pharma, Inc. (ATYR)?
How does the current ROE for aTyr Pharma, Inc. (ATYR) compare to its historical average?